Latest News and Press Releases
Want to stay updated on the latest news?
-
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial for AL001 Treatment of Post-Traumatic Stress Disorder at Massachusetts General Hospital
-
Pune, Feb. 13, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Post-traumatic Stress Disorder Market is expected to clock US$ 1.51 billion by...
-
Covina, Sept. 21, 2023 (GLOBE NEWSWIRE) -- What is Post-Traumatic Stress Disorder Therapy Market? Post-traumatic stress disorder is a condition of mental health that developed in an...
-
New York, USA, May 09, 2023 (GLOBE NEWSWIRE) -- Post-Traumatic Stress Disorder Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR),“Post-Traumatic...
-
NEWARK, Del, March 10, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Post-Traumatic Stress Disorder (PTSD) Treatment Market is expected to grow at a value of 5% CAGR,...
-
Burlingame, Feb. 15, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global post-traumatic stress disorder market is estimated to be valued at US$ 1034.3 million in 2022 and is...
-
London, UK – 3 November 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
-
LOS OSOS, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Author Arthur H. Mooneyhan, who spent more than three decades working in the U.S. prison system, has published a compelling nonfiction book that...
-
EVANSTON, Ill., June 18, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...